CD40 and central nervous system cancer: However, TLS formation induced by immunostimulatory agonistic CD40 antibodies was observed to impair the efficacy of anti-PD-1 antibodies (αPD-1) in murine gliomas through the accumulation of CD11b-expressing B cells, which may inhibit CD8+ T cell responses [11].